SCHEMBL21623397

SCHEMBL21623397

Brc1ccn2c(c1)nc1ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 3/20 0.48
NPM1 P06748 1/20 0.46
PTPN1 P18031 2/20 0.43
PTPN2 P17706 1/20 0.43
ADORA2A P29274 2/20 0.43
ADORA1 P30542 1/20 0.43
ALDH1A1 P00352 7/20 0.42
KDM4E B2RXH2 6/20 0.42
HPGD P15428 5/20 0.42
GLA P06280 3/20 0.42
GAA P10253 3/20 0.42
POLB P06746 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAPT P10636 5/20 0.41
AKT2 P31751 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31031257 0.84 ALDH1A1 (0.41) ALKNPM1ALDH1A1KDM4EHPGD
SCHEMBL24553487 0.79 PTPN2 (0.51) ALKPTPN1PTPN2ALDH1A1KDM4E
SCHEMBL832843 0.79 RAD51 (0.51) ALKPTPN1PTPN2ADORA2AADORA1
SCHEMBL18838772 0.78 IKBKB (0.47) ALKNPM1ALDH1A1KDM4EHPGD
SCHEMBL12324751 0.78 NPM1 (0.43) ALKNPM1ALDH1A1KDM4EHPGD
SCHEMBL22906838 0.77 KDR (0.50) ALKPTPN1PTPN2ADORA2AALDH1A1
SCHEMBL18015436 0.77 KDM4E (0.64) ALDH1A1KDM4EHPGDGLAGAA
SCHEMBL839837 0.75 ALDH1A1 (0.62) PTPN1PTPN2ALDH1A1KDM4EHPGD
SCHEMBL18548730 0.75 ALDH1A1 (0.43) ALKPTPN1PTPN2ALDH1A1KDM4E
SCHEMBL25457542 0.75 ADORA2A (0.44) ALKPTPN1PTPN2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658651-A1 NOVEL COMPOUNDS FOR TAU IMAGING Eli Lilly and Company (US) 2025-12-10 EP disclosed
CN-119285633-A Hydrophobic tag compound for targeted degradation of Tau protein, preparation and application thereof 中国药科大学 2025-01-10 CN disclosed
WO-2024163546-A1 NOVEL COMPOUNDS FOR TAU IMAGING ELI LILLY AND COMPANY (US) 2024-08-08 WO disclosed
US-11581497-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-02-14 US disclosed
EP-3820966-B1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2022-06-08 EP disclosed
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-14 US disclosed
WO-2020011686-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2020-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11581497-B2 Materials for organic electroluminescent devices OR10J3, EPCAM, L1CAM ALK 1054/4885NPM1 224/4885PTPN1 4312/4885
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, EPCAM, L1CAM ALK 1054/4885NPM1 224/4885PTPN1 4312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.